Cue Biopharma, Inc. Other Loans Payable
Cue Biopharma, Inc. (CUE) had Other Loans Payable of $535.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:OtherLoansPayable · last filed 2025-05-12
- 2025-03-31: Other Loans Payable $535.00K.
- 2024-12-31: Other Loans Payable $0.00.
| Period end | Other Loans Payable |
|---|---|
| 2025-03-31 | $535.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |